AngioDynamics
ANGO
121 hedge funds and large institutions have $302M invested in AngioDynamics in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 50 increasing their positions, 34 reducing their positions, and 12 closing their positions.
919% more call options, than puts
Call options by funds: $1.58M | Put options by funds: $155K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
47% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 34
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
3% more capital invested
Capital invested by funds: $293M → $302M (+$9.46M)
0% more funds holding
Funds holding: 121 → 121 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$3.19M |
| 2 |
Bank of New York Mellon
New York
|
+$1.1M |
| 3 |
RA
Royce & Associates
New York
|
+$884K |
| 4 |
Renaissance Technologies
New York
|
+$819K |
| 5 |
State Street
Boston,
Massachusetts
|
+$722K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.76M |
| 2 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$1.38M |
| 3 |
Two Sigma Advisers
New York
|
-$709K |
| 4 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
-$698K |
| 5 |
Two Sigma Investments
New York
|
-$641K |
ANGO Hedge Fund Activity: Q1 2016 in Review
121 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2016, worth a combined $302M — up 3.2% from $293M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new ANGO positions and 12 closed out — a net gain of 1 holder — while 50 added to existing stakes and 34 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $3.19M. The largest seller was Millennium Management, cutting an estimated $2.76M.
- 121 institutional investors held AngioDynamics (ANGO) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $302M of AngioDynamics stock for Q1 2016, up 3.2% quarter-over-quarter.
- 13 funds opened new AngioDynamics positions in Q1 2016 and 12 closed out, a net change of +1 holder.
- The largest AngioDynamics buyer in Q1 2016 was JP Morgan Chase, an estimated $3.19M added.
- The largest AngioDynamics seller in Q1 2016 was Millennium Management, an estimated $2.76M sold.
Based on aggregated 13F filings for Q1 2016.